Tags

Type your tag names separated by a space and hit enter

Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
Vaccine. 2018 02 21; 36(9):1183-1189.V

Abstract

BACKGROUND

Infection with hepatitis A and hepatitis B virus can increase the risk of morbidity and mortality in persons with chronic liver disease (CLD). The Advisory Committee on Immunization Practices recommends hepatitis A (HepA) and hepatitis B (HepB) vaccination for persons with CLD.

METHODS

Data from the 2014 and 2015 National Health Interview Surveys (NHIS), nationally representative, in-person interview surveys of the non-institutionalized US civilian population, were used to assess self-reported HepA (≥1 and ≥2 doses) and HepB vaccination (≥1 and ≥3 doses) coverage among adults who reported a chronic or long-term liver condition. Multivariable logistic regression was used to identify factors independently associated with HepA and HepB vaccination among adults with CLD.

RESULTS

Overall, 19.4% and 11.5% of adults aged ≥ 18 years with CLD reported receiving ≥1 dose and ≥2 doses of HepA vaccine, respectively, compared with 14.7% and 9.1% of adults without CLD (p < .05 comparing those with and without CLD, ≥1dose). Age, education, geographic region, and international travel were associated with receipt of ≥2 doses HepA vaccine among adults with CLD. Overall, 35.7% and 29.1% of adults with CLD reported receiving ≥1 dose and ≥3 doses of HepB vaccine, respectively, compared with 30.2% and 24.7% of adults without CLD (p < .05 comparing those with and without CLD, ≥1 dose). Age, education, and receipt of influenza vaccination in the past 12 months were associated with receipt of ≥3 doses HepB vaccine among adults with CLD. Among adults with CLD and ≥10 provider visits, only 13.8% and 35.3% had received ≥2 doses HepA and ≥3 doses HepB vaccine, respectively.

CONCLUSIONS

HepA and HepB vaccination among adults with CLD is suboptimal and missed opportunities to vaccinate occurred. Providers should adhere to recommendations to vaccinate persons with CLD to increase vaccination among this population.

Authors+Show Affiliations

Leidos Inc., Atlanta, GA, United States. Electronic address: hwg3@cdc.gov.Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.Leidos Inc., Atlanta, GA, United States.Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.Division of Viral Hepatitis, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29395521

Citation

Yue, Xin, et al. "Hepatitis a and Hepatitis B Vaccination Coverage Among Adults With Chronic Liver Disease." Vaccine, vol. 36, no. 9, 2018, pp. 1183-1189.
Yue X, Black CL, O'Halloran A, et al. Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease. Vaccine. 2018;36(9):1183-1189.
Yue, X., Black, C. L., O'Halloran, A., Lu, P. J., Williams, W. W., & Nelson, N. P. (2018). Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease. Vaccine, 36(9), 1183-1189. https://doi.org/10.1016/j.vaccine.2018.01.033
Yue X, et al. Hepatitis a and Hepatitis B Vaccination Coverage Among Adults With Chronic Liver Disease. Vaccine. 2018 02 21;36(9):1183-1189. PubMed PMID: 29395521.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease. AU - Yue,Xin, AU - Black,Carla L, AU - O'Halloran,Alissa, AU - Lu,Peng-Jun, AU - Williams,Walter W, AU - Nelson,Noele P, PY - 2017/04/03/received PY - 2018/01/08/revised PY - 2018/01/11/accepted PY - 2018/2/6/pubmed PY - 2018/10/13/medline PY - 2018/2/4/entrez KW - Chronic liver disease KW - Hepatitis A vaccination KW - Hepatitis B vaccination KW - National Health Interview Survey SP - 1183 EP - 1189 JF - Vaccine JO - Vaccine VL - 36 IS - 9 N2 - BACKGROUND: Infection with hepatitis A and hepatitis B virus can increase the risk of morbidity and mortality in persons with chronic liver disease (CLD). The Advisory Committee on Immunization Practices recommends hepatitis A (HepA) and hepatitis B (HepB) vaccination for persons with CLD. METHODS: Data from the 2014 and 2015 National Health Interview Surveys (NHIS), nationally representative, in-person interview surveys of the non-institutionalized US civilian population, were used to assess self-reported HepA (≥1 and ≥2 doses) and HepB vaccination (≥1 and ≥3 doses) coverage among adults who reported a chronic or long-term liver condition. Multivariable logistic regression was used to identify factors independently associated with HepA and HepB vaccination among adults with CLD. RESULTS: Overall, 19.4% and 11.5% of adults aged ≥ 18 years with CLD reported receiving ≥1 dose and ≥2 doses of HepA vaccine, respectively, compared with 14.7% and 9.1% of adults without CLD (p < .05 comparing those with and without CLD, ≥1dose). Age, education, geographic region, and international travel were associated with receipt of ≥2 doses HepA vaccine among adults with CLD. Overall, 35.7% and 29.1% of adults with CLD reported receiving ≥1 dose and ≥3 doses of HepB vaccine, respectively, compared with 30.2% and 24.7% of adults without CLD (p < .05 comparing those with and without CLD, ≥1 dose). Age, education, and receipt of influenza vaccination in the past 12 months were associated with receipt of ≥3 doses HepB vaccine among adults with CLD. Among adults with CLD and ≥10 provider visits, only 13.8% and 35.3% had received ≥2 doses HepA and ≥3 doses HepB vaccine, respectively. CONCLUSIONS: HepA and HepB vaccination among adults with CLD is suboptimal and missed opportunities to vaccinate occurred. Providers should adhere to recommendations to vaccinate persons with CLD to increase vaccination among this population. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/29395521/Hepatitis_A_and_hepatitis_B_vaccination_coverage_among_adults_with_chronic_liver_disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(18)30068-9 DB - PRIME DP - Unbound Medicine ER -